Evidence map›Paper›PMID 29507652›Full record

ArticleOxidative medicine and cellular longevity2018

36H: A Novel Potent Inhibitor for Antimelanogenesis.

Li-Ching Lin, Chung-Yi Chen, Chia-Hung Kuo, Yun-Sheng Lin, Byeong Hee Hwang, Tina Kaiting Wang, Yueh-Hsiung Kuo, Hui-Min David Wang

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oxidative medicine and cellular longevity, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Purified Astaxanthin fromOxidative medicine and cellular longevity · 2020
    Article
  5. A Novel Oral Astaxanthin Nanoemulsion fromOxidative medicine and cellular longevity · 2020
    Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 5 countries.

Li-Ching LinDepartment of Fragrance and Cosmetic Science, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
Chung-Yi ChenSchool of Medical and Health Sciences, Fooyin University, Kaohsiung 831, Taiwan.
Chia-Hung KuoDepartment of Seafood Science, National Kaohsiung Marine University, Kaohsiung 811, Taiwan.
Yun-Sheng LinDepartment of Biological Science and Technology, Meiho University, Pingtung 912, Taiwan.
Byeong Hee HwangDivision of Bioengineering, Incheon National University, Incheon, Republic of Korea.
Tina Kaiting WangUniversity of British Columbia, Department of Integrated Sciences for Physiology and Behavioural Neuroscience, Vancouver, BC, Canada.
Yueh-Hsiung KuoDepartment of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung 404, Taiwan.ORCID 0000-0001-5935-6755
Hui-Min David WangGraduate Institute of Biomedical Engineering, National Chung Hsing University, Taichung 402, Taiwan.ORCID 0000-0002-4692-4917
Kaohsiung Medical University · TWAsia University · TWFooyin University · TWIncheon National University · KRMeiho University · TWNational Kaohsiung Marine University · TWUniversity of British Columbia · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsAntioxidantsCinnamatesEnzyme InhibitorsHumansMelaninsMelanocytesMiceMonophenol MonooxygenaseSkin Lightening PreparationsAntioxidantsCinnamatesEnzyme InhibitorsMelaninsMonophenol MonooxygenaseSkin Lightening Preparations

Identifiers

PMID29507652
PMCPMC5817369
OpenAlexW2788215568

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.